Table 1 |
||
|
Primers used in the study |
||
|
Primer |
Sense/antisense |
Sequence |
|
|
||
|
HO-1 |
Sense |
CAGGCAGAGAATGCTGAG |
|
Antisense |
GCTTCACATAGCGCTGCA |
|
|
TLR2 |
Sense |
TGACTGCTCGGAGTTCTCCC |
|
Antisense |
GTCAGCACCAGAGCCTGGAG |
|
|
TLR4 |
Sense |
GCGGCTCGAGGAAGAGAAGA |
|
Antisense |
AGGCTCTGATATGCCCCATC |
|
|
GAPDH |
Sense |
ACAGTCAGCCGCATC |
|
Antisense |
AGGTGCGGCTCCCTA |
|
|
TNF-α |
Sense |
ATGAGCACTGAAAGCATGATC |
|
Antisense |
GGCGATGCGGCTGATGGT |
|
|
CD14 |
Sense |
CGGCCGAAGAGTTCACAAGT |
|
Antisense |
AGTGCAGTCCTGTGGCTTC |
|
|
MD-2 |
Sense |
TAAATCTTTTCTGCTTACTGA |
|
Antisense |
TACTCAATTTATTCTAATTTGAAT |
|
|
|
||
|
HO, heme oxygenase; MD, Myeloid differentiation factor-2 ; TLR, Toll-like receptor; TNF, tumor necrosis factor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. |
||
|
Kirino et al. Arthritis Research & Therapy 2008 10:R16 doi:10.1186/ar2367 |
||
